Venture capital firms Originate Ventures and Osage Venture Partners reinvested alongside Kaplan Ventures after backing ProtonMedia's $2.5m series A round.

Best Buy Capital, the corporate venturing unit of US retailer Best Buy, has led the $5.5m series B round for local mobile health and fitness company Valencell.

Tesaro is focused on cancer-related products having licensed two programmes from Opko and Amgen since December and just raised $101m.

US-based renewable energy company General Compression has closed the first tranche of its $54.5m series B round after starting its first wind farm in Texas with investor and oil major ConocoPhillips.

Kovio, a US-based maker of printed silicon semiconductors, has raised $15m in its series B round from a consortium led by Tyco Retail Solutions, a unit of industrial conglomerate Tyco International, as a new investor.

The corporate venturing arm of technology equipment maker Qualcomm has joined a $10m funding round raised by US and Netherlands-based semiconductor manufacturer Cavendish Kinetics.

The corporate venturing unit of UK-listed pharmaceutical company GlaxoSmithKline has participated in the extension financing raised by US drugs company Constellation Pharmaceuticals.

French drugs company Sanofi has led the $7.5m round into cancer treatment company Esperance Pharmaceuticals.

The series B round follows Holtzbrinck Ventures (HV) spinning out from German media parent Georg von Holtzbrinck Publishing Group.

Kaiser Permanente Ventures, the corporate venturing unit of the US's largest health care system, has joined the consortium investing $45m in the series B round for Agile Therapeutics, which is making a contraceptive patch for women.